Circadian rhythms control aspects of physiological events, including lipid metabolism, showing rhythmic fl uctuation over 24 h. Therefore, it is not suffi cient to evaluate thoroughly how dietary components regulate lipid metabolism with a single time-point assay. In the present study, a time-course study was performed to analyze the effect of sea cucumber saponin echinoside A (EA) on lipid metabolism over 24 h. Results showed that EA lowered the levels of TC and TG in both serum and liver at most time-points during the 24 h. Activities of hepatic lipogenic enzymes and lipolytic enzymes were inhibited and elevated respectively by EA to varied degrees at different time-points. Meanwhile, parallel variation trends of gene expression involved in fatty acid synthesis and ␤-oxidation were observed accordingly. The interaction between EA and lipid metabolism showed a time-dependent effect. Overall, EA impaired fatty acid synthesis and enhanced mitochondrial fatty acid ␤-oxidation in ad libitum feeding over 24 h.
Sea cucumber is valued as a traditional seafood in Asia, especially in China, Japan, and Korea. Many bioactive substances, such as saponins, cerebrosides, polysaccharides, and collagen peptides have been found and isolated from sea cucumber. There is growing evidence that dietary sea cucumber could improve lipid metabolism in animals (1, 2) . Saponins, as the most important secondary metabolite and bioactive component of sea cucumber, exhibit various biological activities, such as antifungal, anti-angiogenesis, anti-tumor and immunomodulatory effects (3) (4) (5) . What's more, sea cucumber saponin (SCS) also showed good bioactivities in lipid metabolism, for instance, ameliorating obesity, improving hepatic steatosis (6) and alleviating orotic acidinduced fatty liver (7) . SCS is a complicated mixture of types of triterpene glycosides, and echinoside (EA) is the primary component of it. However little is currently known about how EA alters metabolism. Our previous study showed EA inhibits dietary fat absorption and improves obesity (8) . However, we remain ignorant of the effects of EA on lipid metabolism.
To elucidate the effects of food components on metabolism, most work is based on single-point evaluation. Using a typical protocol (get one sample after fasting), our previous study indicated that SCS inhibits enzyme activity related to fatty acid synthesis and fatty acid ␤-oxidation (7) . Meanwhile, the mRNA levels of sterol regulatory element binding protein-1c (SREBP-1c), a key transcription factor for fatty acid biosynthesis, and its downstream genes fatty acid synthase (FAS), malic enzyme (ME), and glucose-6-phosphate dehydrogenase (G6PDH) were inhibited in an SCS-fed group. mRNA levels of transcription factor peroxisome proliferatoractivated receptor ␣ (PPAR␣), which plays an important role in fatty acid ␤-oxidation and its responders, carnitine palmitoyl transferase 1a (CPT1a) and carnitine palmitoyl transferase 2 (CPT2), were up-regulated after SCS treatment (7) . However, gene expression and activities of many key enzymes related to lipid metabolism operate in circadian rhythm metabolism (9) . Therefore, it is diffi cult to holistically evaluate the effects of dietary components on lipid metabolism by the changes from single time-point samples. Clock genes have been shown to be associated with the pathogenesis of metabolic syndrome, as defi ciency of Bmal1 impairs adipogenesis (10) . In addition, the CLOCK/BMAL1 heterodimer, a circadian gene, plays an important role in lipid homeostasis by transactivating PPAR␣ in mice. The circadian expression of PPAR␣ is directly regulated by CLOCK protein (11) . Apart from circadian rhythm, fasting was also effective in altering the enzyme activities and mRNA expression of genes related to energy and lipid metabolism (12) .
In the present study, we observed the infl uences of EA on lipid metabolism by detecting variation of serum lipids and hepatic lipids, as well as the key enzymatic activity and gene expression involved in lipid synthesis and fatty acid ␤-oxidation during 24 h of ad libitum feeding.
MATERIALS AND METHODS
Preparation of saponins from sea cucumber. Preparation of the saponins from sea cucumber. EA was isolated by the procedure described by Dong (13) . Briefl y, an ethanolic extract of Pearsonothria graeffei was sequentially subjected to macroporous resin, Sigel, and reversed ODS Si-gel chromatography to achieve the fi nal purifi cation of EA. The structure and chromatogram of echinoside A (EA) referenced our previous analysis (8) can be found in Fig. 1 .
Animals and experimental design. Male ICR mice, 4-5 wk, 18-20 g, were purchased from Vital River Laboratory Animal Center (Beijing, China). The usage of animals was approved by Beijing Municipal Science and Technology Commission (Beijing, China) with licensed ID (SCXK2011-0001), which is valid until 2016. They were housed at 23Ϯ1˚C with a12-h light (8:30-20:30)/12-h dark (20:30-8:30) cycle, and allowed free access to food and water to acclimatize to the laboratory environment for 5 d prior to the study. All experimental protocols used in this study were approved by the ethical committee of experimental animal care at Ocean University of China. Sixty ICR male mice were randomized to either the EA (containing 0.03% echinoside A in regular chow, nϭ30) group or control group (regular chow, nϭ30). After 2 wk, fi ve mice in each group were killed at CT8, CT12, CT16, CT20, CT0, CT4 (CT means clock time). Liver was quickly excised, weighed, frozen in liquid nitrogen, and stored at Ϫ80˚C until analysis.
Serum and hepatic lipid determination. Serum was collected and stored at Ϫ80˚C for further analysis. Hepatic lipids were extracted with chloroform-methanol 2 : 1 as Folch et al. (14) described, and then dissolved using Triton X-100. Hepatic and serum TG and TC concentrations were determined using enzymatic reagent kits (Nanjing Jiancheng Bioengineering Institute, Nanjing, China). Serum free fatty acid (FFA) levels were measured using kits (Wako Pure Chemical Industries, Ltd., Osaka, Japan)
Assays of hepatic enzyme activity. A piece of liver was homogenized in six volumes of a 0.25 M sucrose solution that contained 1 mM EDTA in a 10 mM Tris-HCl buffer (pH 7.4). After the nuclei fraction was precipitated, the supernatant was centrifuged at 10,000 ϫg for 10 min at 4˚C to obtain the mitochondrial fraction. The resulting supernatant was recentrifuged at 125,000 ϫg for 60 min to precipitate microsomes, and the remaining supernatant was used as the cytosol fraction. The protein concentration was determined according to the method of Lowry et al. (15) . Activities of fatty acid synthase (FAS; EC 2.3.1.85) (16) glucose 6-phosphate dehydrogenase (G6PDH; EC 1.1.1.49) (17), malic enzyme (ME; EC 1.1.1.40) (18) , mitochondrial carnitine palmitoyl transferase (CPT; EC 2.3.1.21) (19) , and peroxisomal ␤-oxidation enzyme (EC 1.3.3.6) (20) were determined as described.
RNA purifi cation and quantitative real time PCR. mRNA levels of related genes were measured by real Table 1 . Primer sequences used for qRT-PCR analysis of gene expression in the liver tissue of ICR mice.
Gene
Forward and reverse primer time reverse transcription-polymerase chain reaction (real time RT-PCR). Total RNA was extracted from liver tissue using a Trizol Reagent (Invitrogen, Tokyo, Japan). One microgram total RNA were reverse transcribed into cDNA using random primer (Toyobo, Osaka, Japan 
RESULTS
As shown in Fig. 2 , there was fl uctuation in serum TG, FFA and TC levels at different time-points in both the control and EA group. Asimilar daily pattern of serum TC and FFA was shown in the control group (Fig.  2B , C). Administration of EA obviously diminished the levels of serum TG (at CT12, CT0, and CT4, pϽ0.01) and elevated the levels of serum FFA (at all time-points, pϽ0.01) without rhythmic alteration of them. Lower (at CT8, CT16, CT0, pϽ0.05), with a single time-point higher (at CT4, pϽ0.01), levels of serum TC were exhibited in the EA group compared with that of the control group (Fig. 2C) . Meanwhile, the peak phase of serum TC moved from CT8 (in the control group) to CT12 after EA supplementation. The daily pattern of serum TBA concentration was opposite to that of TC in both groups (Fig. 2C, D) . EA signifi cantly changed the daily rhythm of TBA, increasing the TBA level at CT16, CT0, and CT4 but lowering it at CT8 (Fig. 2D, pϽ0.05) . Likewise, hepatic TC and TG also showed diurnal variation and a parallel diurnal pattern of hepatic TC was shown in the two groups. A lower trend of hepatic TC with a decreased peak value and slightly higher levels at 0:00 were shown in the EA group (Fig. 3A) . In contrast, EA signifi cantly changed the peak value times (shifted from CT12 and CT0 to CT8 and CT20) and reduced the content of hepatic TG at other time-points (Fig. 3B) .
We examined the activities of hepatic critical enzymes involved in the biosynthesis of lipids, including FAS, ME and G6PDH, throughout the 24 h free feeding. As shown in Fig. 4 , the activities of all of the above enzymes fl uctuated over 24 h. Signifi cantly decreased activity of enzyme FAS (Fig. 4A ) and G6PDH (Fig. 4B ) was shown at most detected time points in the EA group. However, EA obviously shifted the diurnal rhythm of ME activity, with higher ( Fig. 4C , at CT4, CT16, CT20, pϽ0.01) and lower (Fig. 4C, at CT0, pϽ0.01) activity.
The activity of fatty acid ␤-oxidation was measured using hepatic peroxisome and mitochondria respectively ( Fig. 5 ). Under ad libitum feeding, the activity of fatty acid ␤-oxidation was time-dependent wavy in both peroxisome and mitochondria in the two groups (Fig. 5A,  B) . The highest activity of peroxisome and mitochondria presented at CT12 and CT0 respectively in the control group. After supplementation of EA, accordant activity rhythm of mitochondria and peroxisome presented. Moreover, EA-caused elevated activity was observed at most time-points for mitochondria ( Fig. 5B, pϽ0 .05) but only at CT20 and CT4 for peroxisome ( Fig. 5B, pϽ0.05) .
To explore the molecular mechanism by which EA may regulate the different transcription factors and enzymes involved in lipid metabolism, we examined the expression of hepatic genes that regulate lipogenesis. As we expected, the expression of SREBP1c and its target gene FAS showed a similar daily rhythm in the control group (Fig. 6A, B) . EA markedly altered the fl uctuation mode of SREBP1c and FAS but still kept their consistency. In addition, accordantly decreased expression lev- els of SREBP1c and FAS were observed at CT8, CT16, CT4 and CT20 in the EA group. However, the daily patterns of G6PDH and ME were different from those of SREBP1c and FAS in the control group and EA obviously changed them (Fig. 6C, D) . A signifi cantly reduced level of G6PDH at daytime points (Fig. 6C , at CT8, pϽ0.05; at CT12, pϽ0.01) with mildly increased mRNA expression at a nighttime point (Fig. 6D, at CT0, pϽ0.01) was shown in the EA group. Lower or higher expression levels of ME mRNA were observed at CT8 and CT20, and CT12 and CT4, respectively, in the EA group (Fig.  6C ). In addition, a similar daytime rhythm of SREBP2 and its downstream gene hydroxy-3-methyl-glutaryl-COA reductase (HMGCR) was observed in the control group (Fig. 6E, F) , as well as an altered daily pattern of SREBP2 with signifi cant elevation (at CT12, CT16, CT0, pϽ0.05) and reduction (at CT20 and CT4, pϽ0.05) in the EA group. Obviously increased (pϽ0.05) expression levels of HMGCR appeared at most time-points in the EA group.
To determine the effects of EA on hepatic lipolysis, we performed further analysis by detecting related gene expression. As shown in Fig. 7 , the 24 h expression pattern of PPAR␣ was similar to that of CPT1a but different from that of CPT2 in the control group. However, the daily expression patterns of CPT1a and CPT2 were alike but distinct from those of PPAR␣ and CD36 in the EA group. Moreover, EA elevated the expression levels of PPAR␣ (at CT8, CT20, CT4, CT16, pϽ0.05), CPT1a (at CT4, CT8, CT12, CT16, pϽ0.05), CPT2 (at CT12, CT16, CT0, CT4, pϽ0.05), and CD36 (at CT4,CT8, CT16, CT24, pϽ0.05) to varied degrees.
DISCUSSION
Physiology and metabolism are driven by cell autonomous clocks which are synchronised by environmental cycles (such as food and light), and maintain ~24 h rhythms (21) . Hence, metabolic state varies with circadian rhythm during the course of 24 h. Different physiological responses to the same dietary component will occur at different time phases. Therefore, it is necessary to evaluate the infl uence of dietary components on lipid metabolism over 24 h rather than test at one time phase only. Moreover, PPAR␣, FAS and G6PDH, which are related to lipids metabolism, have been found to exist in daily rhythm in gene expression or enzyme activity in our previous and other studies (22) (23) (24) . In addition, Kerndt et al. (25) discovered that changes in metabolic fuel occur rapidly after the start of a fasting period. For instance, triacylglycerol and cholesterol levels of liver and serum dropped after only a 6 h fasting period, accompanied by increased serum free fatty acid (FFA). Meanwhile, lipolysis and lipogenesis were enhanced and inhibited, respectively, at related genetic and enzymic levels (25, 26) . Moreover, the quantity of food (food intake) could also affect the activity of enzymes and gene expression involved in lipid metabolism. We did not analyse the difference in food intake between the two groups at different time phases but the total food intake showed no signifi cant difference between the groups (data not shown).
The present results showed that the serum TG level decreased across the day, especially at the dark phase (feeding phase) in the EA group under free feeding. This was partly caused by the reduction of dietary lipid assimilation since EA could inhibit pancreatic lipase activity (8) . On the other hand, the higher serum FFA level together with the accordant decline in TG levels of serum and liver, may be ascribed to its regulation of hepatic lipid metabolism. Therefore, we next studied the activity and gene expression of those factors involved in hepatic lipid synthesis and lipidolysis. SREBP1c activates lipogenic factors such as FAS, G6PDH and ME (27, 28) . Dietary EA obviously decreased the mRNA abundance of SREBP1c across the day, especially at 8:00, 16:00 and 4:00 (3 to 23 times lower than the control). In the present study, the peak of SREBP-1 occurred at the end of the night/beginning of the day, consistent with a previous study (29) , and also appeared at 16:00. FAS showed its peak at the end of the night/beginning of the day, which was similar to previous studies under the nighttime feeding mode (24, 29) . What's more, the alteration (daily rhythm and reduced abundance) in mRNA expression of FAS was highly in line with that of SREBP1c. The results of enzyme activity related to lipid synthesis indicated that EA signifi cantly and enduringly inhibited the activity of FAS and G6PDH without changing their circadian rhythm during 24 h of ad libitum feeding. By contrast, EA changed the daily rhythm of enzyme activity and discontinuously suppressed the activity of ME only at the dark phase (feeding phase) (Fig. 5C ). The discordance is probably due to the fact that ME is involved in both glucose and lipid metabolism. Therefore, EA may also infl uence glucose metabolism. Our data demonstrated that EA down-regulated SREBP1c-FAS-mediated lipid synthesis to repress hepatic lipid synthesis.
As for cholesterol synthesis, EA elevated the mRNA expression of SREBP2 and HMGCR. In the face of the contradiction between decreased TC level of both serum and liver and increased expression of genes involved in cholesterol synthesis, we speculated that EA promoted the excretion of fecal cholesterol, which caused a compensatory increase in cholesterol synthesis (8) . Moreover, the peak phase of HMGCR expression was shown in the nighttime phase, which is consistent with a previous result (30) , and changed to the daytime phase after EA administration. Cholesterol 7␣-hydroxylase (CYP7A1), the rate-limiting enzyme in the neutral pathway of bile acid biosynthesis, is feedback-inhibited at the transcriptional level by hydrophobic bile acids (31) . In the present results, EA signifi cantly suppressed the gene expression of CYP7A1, and increased serum TBA concentration during the nighttime phase ( Fig. 6G) meanwhile, indicating the potential feedback inhibition.
Peroxisomal ␤-oxidation and mitochondrial ␤-oxidation are the two routes of fatty acid beta-oxygenolysis in cells. Mitochondrial ␤-oxidation usually was taken as primary in normal physiology. In the present study, EA either elevated or depressed peroxisomal ␤-oxidation activity at different time-points. However, signifi cantly and permanently elevated mitochondria ␤-oxidation activity was shown over 24 h in the EA group. Previous studies have demonstrated that CD36 could transfer long chain fatty acids (LCFAs) into the mitochondria and has an important role in lipid homeostasis (32) . EA enhanced the mRNA expression of genes CD36, PPAR␣, CPT1a and CPT2. This phenomenon suggested that EA promoted not only the uptake of LCFA to mitochondria but also the mitochondrial fatty acid ␤-oxidation activity during the 24 h period.
In peripheral clocks such as the liver, a coordinated action to integrate the circadian clock and physiological activities is necessary. It has been demonstrated that the CLOCK/BMAL1 heterodimer plays an important role in lipid homeostasis by trans-activating PPAR␣ in mice (11) . PPAR␣ is expressed abundantly in the liver where oxidation occurs in the mitochondria and peroxisomes (33) . The expression of PPAR␣ mRNA in the liver has a robust circadian rhythm. In the present results, the peak of PPAR␣ appeared at 4:00/8:00, consistent with a previous study (34) . EA increased the level of PPAR␣ mRNA expression without changing its diurnal rhythm. A signifi cant fraction of the metabolic transcriptome (including lipid metabolism) in the liver is strongly circadian (35) and mainly entrained by the feeding schedule (36) . Our earlier study found that SCS signifi cantly changed the circadian rhythm (both rhythm and level) of clock genes in the brain rather than that in the liver (24) . Similarly, the present results showed more significant alteration in levels of clock control genes-PPAR␣ and some of its target gene expression level than in diurnal rhythm. It's reported that the resetting of circadian time in peripheral tissues is regulated by glucocorticoid signaling (37) . Our previous study found that SCS might infl uence the circadian rhythm of lipid metabolic genes by corticosterone (24) . Therefore, the alteration of hepatic clock genes (CLOCK/BMAL1) and corticosterone signal might be the triggers for the series changes of gene expression, enzyme activity and metabolites (TG and FFA) level.
In conclusion, the present study provided strong evidence that EA could improve lipid metabolism. The effect of EA on lipid metabolism varies with the rhythmic metabolism state over 24 h under free feeding. Overall, our present data indicated that EA could stimulate mitochondrial fatty acid ␤-oxidation and suppress fatty acid biosynthesis coupled with diurnal rhythm.
